(Amendment No. 21)*
Item 1. Security and Issuer
Item 1 of the Schedule 13D is hereby amended and restated in its entirety as follows:
This Amendment No. 21 to Schedule 13D is being filed by the undersigned to amend the Schedule 13D filed by the Reporting Persons on February 21, 2007, as amended by Amendments Nos. 1-20, the last of which was filed on November 1, 2010 (as amended, the “Schedule 13D”), with respect to the Common Stock, par value $0.01 per share (the “Shares”), of TerreStar Corp (“TerreStar”), whose principal executive offices are located at 12010 Sunset Hills Road, 6th Floor, Reston, VA 20190.
Item 2. Identity and Background
No material change.
Item 3. Source and Amount of Funds or Other Consideration
Item 3 of the Schedule 13D is hereby amended and restated in its entirety as follows:
The beneficial ownership figures on this Schedule 13D reflect an additional purchase of derivative securities convertible into Shares by the Blue Line Fund effected on October 29, 2010. The prior Schedule 13D amendment, filed on November 1, 2010, reflected all other transactions through October 29, 2010 apart from this purchase.
As of November 2, 2010, the Master Fund may be deemed to beneficially own 25,865,956 Shares.
As of November 2, 2010, Harbinger LLC may be deemed to beneficially own 25,865,956 Shares.
As of November 2, 2010, the Special Fund may be deemed to beneficially own 9,001,132 Shares.
As of November 2, 2010, the HCPSS may be deemed to beneficially own 9,001,132 Shares.
As of November 2, 2010, the Blue Line Fund may be deemed to beneficially own 4,598,467 Shares.
As of November 2, 2010, HCP II may be deemed to beneficially own 4,598,467 Shares.
As of November 2, 2010, HCP II GP may be deemed to beneficially own 4,598,467 Shares.
As of November 2, 2010, Harbinger Holdings may be deemed to beneficially own 34,867,088 Shares.
As of November 2, 2010, Philip Falcone may be deemed to beneficially own 39,465,555 Shares.
Item 4. Purpose of Transaction
No material change.
| SCHEDULE 13D | |
CUSIP No.: 881451108 | | | Page 12 of 18 Pages |
Item 5. Interest in Securities of the Issuer
Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:
The beneficial ownership figures on this Schedule 13D reflect an additional purchase of derivative securities convertible into Shares by the Blue Line Fund effected on October 29, 2010. The prior Schedule 13D amendment, filed on November 1, 2010, reflected all other transactions through October 29, 2010 apart from this purchase.
(a, b) As of November 2, 2010, the Master Fund may be deemed to be the beneficial owner of 25,865,956 Shares, constituting 18.1% of the 143,151,084* total Shares outstanding.
The Master Fund has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 25,865,956 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 25,865,956 Shares.
(a, b) As of November 2, 2010, Harbinger LLC may be deemed to be the beneficial owner of 25,865,956 Shares, constituting 18.1% of the 143,151,084* total Shares outstanding.
Harbinger LLC has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 25,865,956 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 25,865,956 Shares.
(a, b) As of November 2, 2010, the Special Fund may be deemed to be the beneficial owner of 9,001,132 Shares, constituting 6.4% of the 140,186,154* total Shares outstanding.
The Special Fund has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 9,001,132 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 9,001,132 Shares.
(a, b) As of November 2, 2010, HCPSS may be deemed to be the beneficial owner of 9,001,132 Shares, constituting 6.4% of the 140,186,154* total Shares outstanding.
HCPSS has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 9,001,132 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 9,001,132 Shares.
(a, b) As of November 2, 2010, the Blue Line Fund may be deemed to be the beneficial owner of 4,598,467 Shares, constituting 3.2% of the 144,064,501* total Shares outstanding.
The Blue Line Fund has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 4,598,467 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 4,598,467 Shares.
(a, b) As of November 2, 2010, HCP II may be deemed to be the beneficial owner of 4,598,467 Shares, constituting 3.2% of the 144,064,501* total Shares outstanding.
| SCHEDULE 13D | |
CUSIP No.: 881451108 | | | Page 13 of 18 Pages |
HCP II has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 4,598,467 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 4,598,467 Shares.
(a, b) As of November 2, 2010, HCP II GP may be deemed to be the beneficial owner of 4,598,467 Shares, constituting 3.2% of the 144,064,501* total Shares outstanding.
HCP II GP has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 4,598,467 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 4,598,467 Shares.
(a, b) As of November 2, 2010, Harbinger Holdings may be deemed to be the beneficial owner of 34,867,088 Shares, constituting 24.2% of the 143,871,204* total Shares outstanding.
Harbinger Holdings has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 34,867,088 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 34,867,088 Shares.
(a, b) As of November 2, 2010, Mr. Falcone may be deemed to be the beneficial owner of 39,465,555 Shares, constituting 26.6% of the 148,469,671* total Shares outstanding.
Mr. Falcone has the sole power to vote or direct the vote of 0 Shares; has the shared power to vote or direct the vote of 39,465,555 Shares; has sole power to dispose or direct the disposition of 0 Shares; and has shared power to dispose or direct the disposition of 39,465,555 Shares.
* This figure is based on 139,466,034 Shares outstanding (as of August 2, 2010, according to the Issuer’s most recent Form 10-Q, filed on August 6, 2010), adjusted for derivative securities held by the Reporting Person.
(c) The trading dates, number of Shares acquired and disposed of, and the price per share for all transactions in the Shares by the Reporting Persons in the past sixty days, separate from the transactions reported on the prior Schedule 13D amendment, are set forth in Exhibit B. These transactions were all open-market.
(d) This Item 5(d) is not applicable.
(e) This Item 5(e) is not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer.
This Item 6 is not applicable.
Item 7. Material to be Filed as Exhibits.
Exhibit A: Joint Filing Agreement
Exhibit B: Schedule of Transactions
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Attention: Intentional misstatements or omissions of fact constitute federal violations (see 18 U.S.C. 1001).